MAUNA KEA TECHNOLOGIES Categorie -O- News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

08.02.17	Mauna Kea Technologies Secures a €7.0 Million Debt Financing (Businesswire)
17.11.16	Mauna Kea Technologies Secures an Equity Financing Facility to Support Its Development (Businesswire)
03.11.16	Mauna Kea Technologies Announces Reimbursement Increases of 131% for Hospitals and 86% for Ambulatory Surgical Centers for Key Cellvizio Procedures (Businesswire)
02.11.16	Mauna Kea Technologies Reports Third Quarter 2016 Sales (Businesswire)
19.10.16	Cellvizio®’s Strong Clinical Efficacy in the Prevention of Certain Pancreatic Cancers Confirmed by Positive Results from Contact Study Presented at UEGW 2016 (Businesswire)
12.10.16	Mauna Kea Technologies: Leading American Clinical Researchers Launch Ground-Breaking Study of Cellvizio for Pediatric Cardiac Surgery (Businesswire)
21.10.14	Mauna Kea Technologies: Physicians Using Optical Biopsy with Cellvizio Discover a New Diagnostic Criterion Specific for Benign Pancreatic Cysts and Invisible with Other Imaging Technologies (Businesswire)
15.10.14	Mauna Kea Technologies Announces Sales Growth of 18% in Q3 2014 (Businesswire)
13.10.14	Mauna Kea Technologies : Success and Strong Attendance for Cellvizio at the Annual Chinese Conference of Digestive Endoscopy, Ccdd 2014 (Businesswire)
23.09.14	Mauna Kea Technologies: Major Success for Cellvizio at the EUS 2014 Conference (Businesswire)
28.08.14	Mauna Kea Technologies: Financial Results for Half Year 2014 (Businesswire)
29.07.14	Mauna Kea Technologies Receives 510(K) Regulatory Clearance from U.S. FDA for New Cellvizio System Functioning in a near-Infrared Wavelength (Businesswire)
16.07.14	Mauna Kea Technologies : H1 2014 Sales: +6% to €4.6 Million (Businesswire)
11.06.14	Mauna Kea Technologies Announces New Board Members (Businesswire)
06.05.14	Mauna Kea Technologies Continues Tradition of Strong Scientific Program with over 40 Cellvizio® Abstracts Presented at Digestive Disease Week 2014 (Businesswire)
28.04.14	Major Step for Optical Biopsy: Mauna Kea Technologies Receives Regulatory Approval for Cellvizio in Japan (Businesswire)
17.04.14	Mauna Kea Technologies Reports the Success of ICCU 2014 and Announces the Implementation of Several Institutional Training Programs on Optical Biopsy (Businesswire)
09.04.14	Mauna Kea Technologies: Full-Year 2013 Results in Line with Expectations (Businesswire)
31.03.14	Mauna Kea Technologies Shares Eligible for New PEA-PME Savings Plan (Businesswire)
31.03.14	Mauna Kea Technologies Installs First Three Cellvizio Systems and Obtains Key Regulatory Clearances in Brazil (Businesswire)
18.03.14	Three Prestigious French Clinics Now Equipped with Cellvizio (Businesswire)
05.03.14	Mauna Kea Technologies Receives 510(k) Regulatory Clearance from U.S. FDA for Cellvizio in Urology (Businesswire)
19.02.14	Mauna Kea Technologies Installs First Cellvizio System in India at Apollo Gleneagles Hospital Kolkata (Businesswire)
13.01.14	Mauna Kea Technologies Announces Centers for Medicare and Medicaid Services Set New Physician Payments for Upper GI Endoscopy with Cellvizio® Optical Endomicroscopy (Businesswire)
08.01.14	Mauna Kea Technologies Announces Its 2013 FY Sales (Businesswire)
12.12.13	Mauna Kea Technologies Partners with the Imperial College of London to Advance Research and Applications of Optical Biopsy with Cellvizio (Businesswire)
11.12.13	Mauna Kea Technologies : 2014 Financial Calendar (Businesswire)
02.12.13	Mauna Kea Technologies Receives the Visit of French President, Francois Hollande (Businesswire)
21.11.13	Mauna Kea Technologies : CE Mark for a Complete Range of Probes Dedicated to Urology (Businesswire)
14.11.13	Mauna Kea Technologies Launches EVA, a Unique Optical Biopsy Operating System Creating a Completely Seamless Customer Experience (Businesswire)
05.11.13	Mauna Kea Technologies : First Use of Optical Biopsy with Cellvizio® in Robotic Assisted Prostatectomy Presented at 31st World Congress of Endourology (Businesswire)
10.10.13	Mauna Kea Technologies Reports Third Quarter 2013 Sales Up 32 % to €2.73m (Businesswire)
19.09.13	Mauna Kea Technologies Announces Strong Presence at Asia-Pacific Digestive Week / World Congress of Gastroenterology 2013 (Businesswire)
30.08.13	Mauna Kea Technologies Reports Financial Results for Half-Year 2013 (Businesswire)
25.07.13	Mauna Kea Technologies Announces Global Expansion of Cellvizio LAB Distribution Network in Pre-Clinical Research (Businesswire)
16.07.13	Mauna Kea Technologies Reports Strong Second Quarter 2013 Sales Growth of +33% To €2.5M (Businesswire)
15.01.13	Mauna Kea Technologies Announces 76% Increase in Full Year 2012 Sales and Record Sales of €3.2 Million in the Fourth Quarter (Businesswire)
07.01.13	Mauna Kea Technologies: 2013 Financial Calendar (Businesswire)
07.01.13	Mauna Kea Technologies Announces Major Step Forward for Reimbursement of Cellvizio Optical Biopsies Performed in Ambulatory Surgery Centers (Businesswire)
13.12.12	Mauna Kea Technologies and Fujifilm Announce Regulatory Approval for Cellvizio® in China for Gastroenterology and Pulmonology (Businesswire)
05.12.12	Mauna Kea Technologies Announces That First Cellvizio Optical Biopsy Probe Designed for Urological Applications is Now CE Marked (Businesswire)
27.11.12	Mauna Kea Technologies Annouces the Publication of World's First Direct Visualization of the Digestive Tract’s Nervous System (Businesswire)
21.11.12	Mauna Kea Technologies Announces the Signature of a Strategic Partnership with University of Edinburgh for Novel Optical Biopsy Device for Pulmonary Applications (Businesswire)
12.11.12	Mauna Kea Technologies Announces Publication of U.S. CPT® Codes and Related Reimbursement Rates for Cellvizio® Procedures in the Upper GI Tract (Businesswire)
15.10.12	Mauna Kea Technologies Reports Third Quarter 2012 Sales (Businesswire)
01.10.12	MAUNA KEA TECHNOLOGIES ANNOUNCES IMPORTANT REGULATORY CLEARANCES IN TURKEY (Businesswire)
18.09.12	Mauna Kea Technologies Announces the Expansion of Its Cellvizio® Surgical Program (Businesswire)
10.09.12	Mauna Kea Technologies Announces Launch of Revolutionary Cellvizio® Dual Band Color Lab Imaging System (Businesswire)
04.09.12	Mauna Kea Technologies Launches Cellvizio® in Brazil (Businesswire)
31.08.12	MAUNA KEA TECHNOLOGIES ANNOUNCES FULL FINANCIAL RESULTS FOR FIRST HALF OF 2012 (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu MAUNA KEA TECHNOLOGIES Categorie -O-

Aktien Top/Flop

Meistgelesene Nachrichten